Psychosocial Adjustment After Radiation Therapy in Patients With Cancer



Status:Completed
Conditions:Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Colorectal Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cognitive Studies, Cognitive Studies, Psychiatric
Therapuetic Areas:Oncology, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:August 2008
End Date:May 2009

Use our guide to learn which trials are right for you!

Psychosocial Adjustment During the Post-Radiation Treatment Transition

RATIONALE: Gathering information about psychological and social adjustment after radiation
therapy in patients with cancer may help doctors plan the best treatment.

PURPOSE: This clinical trial is studying psychosocial adjustment after radiation therapy in
patients with breast cancer, colorectal cancer, lung cancer, or prostate cancer.

OBJECTIVES:

- To describe psychosocial adjustment after radiotherapy in patients with stage I, II, or
III breast, colorectal, lung, or prostate cancer.

- To determine if cognitive appraisal of health predicts psychosocial adjustment of these
patients after radiotherapy.

- To examine whether social support moderates the relationship between cognitive
appraisal of health and psychosocial adjustment of these patients after radiotherapy.

- To examine whether self-efficacy for coping with cancer moderates the relationship
between cognitive appraisal of health and psychosocial adjustment of these patients
after radiotherapy.

- To measure the effect of symptom distress, uncertainty, medical factors, and personal
factors on cognitive appraisal of health of these patients before ending radiotherapy.

OUTLINE: Two weeks before completing planned radiotherapy, patients undergo assessment of
stress appraisal and other factors predictive of post-radiotherapy psychosocial adjustment.
Patients complete psychosocial assessments, including measures of patient perceptions of
their illness (i.e., cognitive appraisal) and of the factors influencing their perceptions
(i.e., uncertainty by the Mishel Uncertainty in Illness Scale-Community Form; symptom
distress by the Memorial Symptom Assessment Scale Short Form; and comorbidity by the
Charlson Comorbidity Index). Measures of patient social support and self-efficacy for coping
are also assessed. At 1 month after completion of radiotherapy, patients undergo repeat
assessment of stress appraisal and psychosocial adjustment.

DISEASE CHARACTERISTICS:

- Diagnosis of breast, colorectal, lung, or prostate cancer

- Stage I, II, or III disease

- Nonmetastatic disease

- Undergoing first course of curative radiotherapy, as indicated in the medical record

- Receiving treatment as an outpatient

- Hormone receptor status not specified

PATIENT CHARACTERISTICS:

- Menopausal status not specified

- Able to receive treatment as an outpatient

- Lives in northeastern Ohio

- Cognitively intact, as evidenced by orientation to person, place, and time

- Has a telephone

- No hearing impairment (must be able to hear instructions)

- No malignancy expected to require surgery or chemotherapy ≤ 2 months after treatment

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- No prior radiotherapy for another type of cancer

- No concurrent or planned chemotherapy or surgery for at least 2 months after
radiotherapy

- No concurrent treatment for recurrent cancer
We found this trial at
1
site
11100 Euclid Ave
Cleveland, Ohio 44106
(216) 844-2273
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center We all know...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials